Rule of lymph node metastasis and proper target of postoperative radiotherapy for thoracic esophageal carcinoma

( views:141, downloads:0 )
Author:
XIAO Ze-fen(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
ZHOU Zong-mei(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
LU Ji-ma(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
LIANG Jun(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
OU Gung-fei(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
JIN Jing(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
SONG Yong-wen(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
ZHANG Shi-ping(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
Yin Wei-bo(Department of Radiation Oncology, Cancer Hospital Institute, Chincse Academy of Medical Sciences,Peking Union Medical College,Beijing 100021 ,China)
Journal Title:
CHINESE JOURNAL OF RADIATION ONCOLOGY
Issue:
Volume 17, Issue 06, 2008
DOI:
Key Word:
Esophageal neoplasms/radiotherapy;Rule of the lymph node metastasis;Field of postoperative radiotherapy

Abstract: Objective To analyze the rule of lymph node metastasis in thoracic esophageal carcinoma,and to study the proper radiation target. Methods From September 1986 to December 1997,549 patients with esophageal carcinoma who had undergone radical reseetion were divided into surgery alone group (S,275 patients) or surgery plus radiotherapy group( S + R,274 patients). Radiotherapy was begun 3 to 4 weeks after operation. The radiation target included beth supra-clavicular areas and the entire mediastinum. The total dose was 50 Gy in 25 fractions over 5 weeks for the supra-clavicular areas and 60 Gy in 30 fractions over 6 weeks for the entire mediastinum. Results The 5-year overall survival of patients with lymph node metastasis in one anatomic site and two anatomic sites was 31.5% and 13.9% (P=0.013), respectively. For patients with > 2 positive nodes metastasis receiving surgery alone, the corresponding 5-year survival was 24.8% and 4.9% (P=0.046) ,respectively. The median number of dissected lymph nodes of the upper-,middle-and lower-segment esophageal carcinoma was 13,17 and 20, respectively. The rate of metastatic lymph node in the para-esophagus region was the highest(61.5%-64.9%) ,which was not different among the different primary sites(P=0.922). The anastomotic stoma recurrence rate of the upper-segment esophageal carcinoma was higher than that of the middle- or lower-segment carcinomas(16.7% ,3.1% ,and 7.7%, χ2=9.02,P<0.05). Conclusions For the thoracic esophageal carcinoma,the number of anatomic sites of lymph node metastasis is an important factor affecting the survival. The lower rate of lymph node metastasis of the upper segment esophageal carcinoma may be corrected with the less lymph node dissected. The rate of lymph node metastasis in para-esophageal region is not related with the lesion segment. The anastemotie stoma is an important radiotherapy target for upper segment esophageal carcinoma.

  • [1]Fok M,Sham JS,Choy D,et al.Postoperative radiotherapy for carcinoma of the esophagus:a prospective,randomized controlled study.Surgery,1993,113:138-147.
  • [2]Tenierc P,Hay JM,Fingerbut A,et al.Postoperative radiation therapy does not increase survival after curative resection for aquamous cell carcinoma of the middle and lower esophagus as shown by a muhicenter controlled trial.Surg Gyneeol Obstet,1991,173:123-129.
  • [3]Zieren HU,Muller JM,Jacobi CA,et al.Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus:a prospective randomized study.World J Surgery,1995,19:444-449.
  • [4]梅泽茹,项其吕,吴维继,等.食管痈术后预防性放疗前瞻性研究.中华放射肿瘤学杂志,1997,6:188-189.
  • [5]XiaoZF,Yang ZY,Liang J,et al.Value of radiotherapy after radical surgery for esophageal earcionma:a report of 495 patients.Ann Thorac Surg,2003,75:331-336.
  • [6]Xiao ZF,Yang ZY,Miao Y J,et al.Influence of number of metastatic lymph node on the survival of curative resected thoracic esophageal cancer and its value of radiotherapy:randomized controlled trial on 549 cases.Int J Radiat Oncol Biol Phys,2005,62:82-86.
  • [7]Skinner DB,Fergnson MD,Soriano A,et al.Selection of operation for esophageal cancer based on staging.Ann Surg,1986,204:391-401.
  • [8]Ellis FH Jr,Heatley GJ,Krasna MJ,et al.Esophagogastreetomy for carcinoma of the esophagus and cardia:a comparison of findings and rcsults after standard resection in three conset:utive eight-year inter-vals with improved staging criteria.J Thorae Cardiovase Surg,1997,113:836-848.
  • [9]Korst RJ,Rusch VW,Venkatmman E,et al.Proposed revision of the staging classification for esophageal cancer.J Thorac Cardiovase Surg,1998,115:660-670.
  • [10]Tachihana M,Kinagasa S,Dhar DK,et al.Dukes' classification as a useful staging system in reset:table squamous cell carcinoma of the esophagus.Virchows Arch,2001,438:350-356.
  • [11]Eloubeidi MA,Deamond R,Arguedas MR,et al.Prognostic factors for the survival of patients with esophageal carcinoma in the U.S:the importance of tumor length and lymph node status.Cancer,2002,95:1434-1443.
  • [12]Kawahara K,Maekawa T,Okabayashi K,et al.The number of lymph node metastasis influences survival in esophageal cancer.J Surg Oncol,1998,67:160-163.
  • [13]Sun KL,Zhang R G,Zhang DW,et al.Influence of lymph node and metastasis on the outcome of surgery for esophageal carcinoma.Chin J Surg,1995,33:222-224.
  • [14]Kato H,Tachimori Y,Watanabe H,et al.Lymph node metastasis in thoracic esophageal eareinama.J Surg Oncol,1991,48:106-111.
  • [15]Abe S,Tachibana M,Shiraish M,et ai.Lymph node metastasis in resectable esophageal cancer.J Thorac Cardiovas,1990,100:287-291.
  • [16]Isono K,Sato H,Nakayama K.Results of nationwide study on the three-field lymph node dissection of esophageal cancer.Ontology,1991,48:411-420.
  • [17]Akiyama H,Tsurumaru M,Kawamura T,et al.Principles of surgical treatment for carcinoma of the esophagus:analysis of lymph node involvement.Ann Surg,1981,194:438-446.
  • [18]Tam PC,Siu KF,Cheung HC,et al.local recurrence after subtotal csophagectomy for squamous cell carcinoma.Ann Surg,1987,205:189-194.
  • [19]周纯武.石木兰,李洪林.食管癌手术后CT扫描随诊的价值.中华放射学杂志,1995,29:608-610.
  • [20]Visbal AL,Allen MS,Miller DL.Ivor lewis esophagogastrectomy for esophageal cancer.Ann Thorac Surg,2001,71:1803-1808.
  • [21]Baba M,Aikou T,Yoshinaka H,et al.Long-term results of suhtotal esophagectomy with three-field lymphedenetctomy for carcinoma of the thoracic esophagus.Ann Surg,1994,219:310-316.
  • [22]Fujita H,Kakegawa T,Yamana H,et al.Mortality and morbidity rates,postoperative course,quality of life,and prognosis after extended radical lymphadenectomy for esophageal cancer,comparison of three-field lymphadenectumy with two-field lymphadenectomy.Ann Surg,1995,222:654-662.
  • [23]Nishimaki T,Suzuki T,Suxuki S,et al.Outcomes of extended radical esophagectomy foe thoracic esophageal cancer.J Am Coil Surg,1998,186:306-312.
  • [24]Tachibana M,Kinagasa S,Dhar DK,et al.Prognostic factors after extended esophagectomy foe squamous cell carcinoma of the thoracic esophagus.J Surg Oncol,1999,72:88-93.
  • [25]Altorki N,Kent M,Ferrara C,et al.Three-field lymph node dissection for squamous cell and adenoearcinoma of the esophagus.Ann Surg,2002,236:177-183.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn